PMCB
PharmaCyte Biotech (PMCB)
$75
About PharmaCyte Biotech (PMCB)
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.
Details
Daily high
$1.84
Daily low
$1.73
Price at open
$1.80
52 Week High
$2.58
52 Week Low
$1.39
Market cap
13.4M
Dividend yield
0.00%
Volume
9
Avg. volume
37,463
P/E ratio
2.59
PharmaCyte Biotech News
Details
Daily high
$1.84
Daily low
$1.73
Price at open
$1.80
52 Week High
$2.58
52 Week Low
$1.39
Market cap
13.4M
Dividend yield
0.00%
Volume
9
Avg. volume
37,463
P/E ratio
2.59